Clinical trial

Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women…

NCT00114270 · University of Virginia, Other · Completed

Key facts

NCT number NCT00114270
Title Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density
Official title Evaluating the Effect of Letrozole With or Without Concomitant Zoledronic Acid on Estrogen Responsive Targets in Postmenopausal Women
Lead sponsor University of Virginia, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Study type Interventional
Conditions Breast Cancer, Osteoporosis
Intervention type Drug
Interventions letrozole, zoledronic acid
Start date May 1, 2004
Completion Jun 1, 2007
First posted Jun 14, 2005
Last update posted Mar 26, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies